Essential thrombocythemia - a predisponent factor for stroke
We present the case of an 81-year-old woman with a history of ischemic stroke in the context of a sustained thrombocytosis, which led to a spinal study and a search for the V617F mutation in the JAK2 gene, which was positive. The patient started cytoreductive therapy with hydroxyurea with favorable current evolution.
Source: Revista da Associacao Medica Brasileira - Category: General Medicine Source Type: research
More News: General Medicine | Genetics | Hemorrhagic Stroke | Ischemic Stroke | Myeloproliferative Disorders | Stroke | Study